Federal authorities are investigating a Centennial biotech company for allegedly defrauding at least 151 investors of more than $10 million by misleading them about new technology to diagnose and treat lung cancer and cardiovascular disease. The regional office of the U.S. Securities and Exchange Commission filed a case in June 2021 against Cell>Point and its subsidiaries, including Cell Theranostics.
Comment on SEC claims Colorado biotech firm bilked investors, allegations the company denies
Judith Kohler, Denver Post: Business
Wed, 03/16/2022 - 5:00am
Comment On This Story
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more